• Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

  • 2023/12/06
  • 再生時間： 29 分
  • ポッドキャスト

『Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective』のカバーアート

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial carcinoma. Single-agent immunotherapies (pembrolizumab and dostarlimab), and now immunotherapy and antiangiogenic therapy combinations (pembrolizumab and lenvatinib), are transforming treatment pathways, with OS benefits in the second-line now achievable. They offer tips for managing the toxicity of these novel therapeutic options and set the stage for 2023, a year which promises a paradigm shift in the use of systemic treatments in this once underserved malignancy.
    続きを読む 一部表示

あらすじ・解説

Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial carcinoma. Single-agent immunotherapies (pembrolizumab and dostarlimab), and now immunotherapy and antiangiogenic therapy combinations (pembrolizumab and lenvatinib), are transforming treatment pathways, with OS benefits in the second-line now achievable. They offer tips for managing the toxicity of these novel therapeutic options and set the stage for 2023, a year which promises a paradigm shift in the use of systemic treatments in this once underserved malignancy.
続きを読む 一部表示

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspectiveに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。